Most biotech firms will be forced to reevaluate foreign relationships and re-route supply chains, or hope for a federal ...
Investing News Network on MSN

Top 5 small-cap biotech stocks of 2025

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to ...
O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
After a weak first half, the drug and biotech sector has recovered in the past 2-3 months with large drugmakers like Pfizer, AstraZeneca, Eli Lilly and Novo Nordisk signing drug pricing agreements ...
The biotech sector has put up a strong recovery in 2025. The Nasdaq Biotechnology Index has risen 33.1% so far this year. The index bottomed out in April 2025 on potential imposition of steep tariffs, ...
While Novartis secured the biggest deal of the fourth quarter, a handful of riveting tales emerged from the bottom of the M&A ...
In a recent report, remote-work site FlexJobs noted that work-from-home job postings recently increased by 3%, indicating ...
UBS gave its highest conviction calls for 2026, laying out its top stock picks across sectors. The bank is bullish on a wide variety of companies spanning several high-growth sectors. A few of its top ...
JPMorgan has released its latest U.S. Analyst Focus List, highlighting top healthcare investment ideas across growth, income, value, and short strategies. The healthcare sector continues to ...